Dynavax Technologies Corporation Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ALKS
Alkermes plc |
$28.50 | $4.05 B | 7.12 | 2100 | $1.66 B |
AMPH
Amphastar Pharmaceuticals, Inc. |
$38.52 | $1.99 B | 13.99 | 1761 | $644.40 M |
ANIP
ANI Pharmaceuticals, Inc. |
$54.23 | $1.40 B | 41.45 | 642 | $486.82 M |
AQST
Aquestive Therapeutics, Inc. |
$3.05 | $250.36 M | -6.11 | 135 | $50.58 M |
COLL
Collegium Pharmaceutical, Inc. |
$33.21 | $1.09 B | 13.22 | 197 | $566.77 M |
DCPH
Deciphera Pharmaceuticals, Inc. |
$25.59 | $2.21 B | -11.57 | 355 | $163.36 M |
DRRX
DURECT Corporation |
$0.82 | $47.18 M | -1.63 | 48 | $8.55 M |
EBS
Emergent BioSolutions Inc. |
$9.34 | $324.37 M | -0.56 | 1600 | $1.05 B |
EGRX
Eagle Pharmaceuticals, Inc. |
$0.65 | $48.18 M | 4.36 | 134 | $316.61 M |
IRWD
Ironwood Pharmaceuticals, Inc. |
$3.65 | $1.01 B | -0.94 | 267 | $442.74 M |
ITCI
Intra-Cellular Therapies, Inc. |
$126.84 | $7.22 B | -58.97 | 610 | $464.37 M |
LNTH
Lantheus Holdings, Inc. |
$92.59 | $5.54 B | 12.18 | 834 | $1.30 B |
NBIX
Neurocrine Biosciences, Inc. |
$139.48 | $13.58 B | 36.58 | 1700 | $1.89 B |
PCRX
Pacira BioSciences, Inc. |
$20.54 | $1.33 B | 18.92 | 711 | $674.98 M |